Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America

• Ross J. Davidson,

  Affiliations Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Canada, Dalhousie University, Halifax, Canada

  ⨯
• Ian Davis,

  Affiliations Lakeridge Health Center, Oshawa, Canada, University of Toronto, Toronto, Canada

  ⨯
• Barbara M. Willey,

  Affiliation Toronto Medical Laboratories/Mount Sinai Hospital Department of Microbiology, Mount Sinai Hospital, Toronto, Canada

  ⨯
• Keyro Rizg,

  Affiliation Dalhousie University, Halifax, Canada

  ⨯
• Shelly Bolotin,

  Affiliation University of Toronto, Toronto, Canada

  ⨯
• Vanessa Porter,

  Affiliation Toronto Medical Laboratories/Mount Sinai Hospital Department of Microbiology, Mount Sinai Hospital, Toronto, Canada

  ⨯
• Jane Polsky,

  Affiliation St. Michael's Hospital Department of Family & Community Medicine, Toronto, Canada

  ⨯
• Nick Daneman,

  Affiliation University of Toronto, Toronto, Canada

  ⨯
• Allison McGeer,

  Affiliations University of Toronto, Toronto, Canada, Toronto Medical Laboratories/Mount Sinai Hospital Department of Microbiology, Mount Sinai Hospital, Toronto, Canada

  ⨯
• Paul Yang,

  Affiliation Ontario Ministry of the Environment, Etobicoke, Canada

  ⨯
• Dennis Scolnik,

  Affiliation University of Toronto, Toronto, Canada

  ⨯
• Roy Rowsell,

  Affiliation Lakeridge Health Center, Oshawa, Canada

  ⨯
• Olga Imas,

  Affiliation Toronto Medical Laboratories/Mount Sinai Hospital Department of Microbiology, Mount Sinai Hospital, Toronto, Canada

  ⨯
• Michael S. Silverman

  * E-mail: msilverman@rogers.com

  Affiliations Lakeridge Health Center, Oshawa, Canada, University of Toronto, Toronto, Canada

  ⨯